of the potential of immune system-derived miRNAs to revolutionize CVD management and
therapy, addressing a major
Chmutin, G,
Antonov, G,
Chmutin, E,
Fedyanin, A,
Livshitz, M,
Oleynikov, B,
Zokhidov, Z,
Shumadalova, A (2022) . The progression of the VBI, especially in the context of inadequate
therapy, often leads to the formation of a
CHEVIDAEV, V.V.,
BOKOV, D.O.,
SAMYLINA, I.A.,
SOKHIN, D.M.,
SERGUNOVA, E.V.,
BOBKOVA, N.V.,
KOVALEVA, T.Y.,
RENDYUK, T.D.,
GRIKH, V.V.,
KRASNYUK, I.I.,
POTANINA, O.G.,
NIKULIN, A.V.,
NASSER, R.A.,
JANULIS, V.,
MOROKHINA, S.L,
GALIAKHMETOVA, E.K.,
MOISEEV, D.V. (2020) %) are presented in monosaccharide composition of PS No 2 polysaccharide
complex. Conclusion: Polysaccharides
Prostatakarzinoms: Eine medizinhistorische Bestandsaufnahme anlässlich 20 Jahre robotisch assistierter
Therapie (Der